Credential Qtrade Securities Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Credential Qtrade Securities Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jul 21, 2025	SELL	$543.48 - $670.97 $915,763 - $1.13 Million	-1,685 Closed	0 $0
Q3 2021 Jul 21, 2025	BUY	$574.03 - $680.96 $106,195 - $125,977	185 Added 12.33%	1,685 $1.02 Billion
Q2 2021 Jul 21, 2025	BUY	$472.8 - $558.54 $198,576 - $234,586	420 Added 38.89%	1,500 $838 Million
Q1 2021 Jul 21, 2025	BUY	$446.73 - $548.2 $482,468 - $592,056	1,080 New	1,080 $511 Million
Q1 2020 Jul 21, 2025	SELL	$336.18 - $494.43 $4,370 - $6,427	-13 Closed	0 $0
Q4 2019 Jul 21, 2025	SELL	$274.13 - $376.51 $4,934 - $6,777	-18 Reduced 58.06%	13 $4.88 Million
Q3 2019 Jul 21, 2025	SELL	$273.46 - $318.39 $1,093 - $1,273	-4 Reduced 11.43%	31 $8.6 Million
Q2 2019 Jul 21, 2025	SELL	$299.6 - $414.82 $63,814 - $88,356	-213 Reduced 85.89%	35 $11 Million
Q1 2019 Jul 21, 2025	SELL	$372.08 - $439.57 $63,997 - $75,606	-172 Reduced 40.95%	248 $102 Million
Q4 2018 Jul 21, 2025	BUY	$335.82 - $403.04 $36,604 - $43,931	109 Added 35.05%	420 $157 Million
Q3 2018 Jul 21, 2025	BUY	$351.14 - $408.51 $109,204 - $127,046	311 New	311 $126 Million

1,449

84.9M

1.39M

1.45M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $60.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Credential Qtrade Securities Inc., based on Form 13F filings with the SEC.

Stay updated on Credential Qtrade Securities Inc. with notifications on news.